Natus Medical

NASDAQ: NTUS · Real-Time Price · USD
32.96
0.00 (0.00%)
At close: Apr 24, 2025, 3:47 PM

Company Description

Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide.

It offers products and technologies used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and neuromuscular diseases.

The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories.

In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions.

Further, the company provides hearing assessment, screening, and instrument fitting solutions; jaundice management products; brain injury products; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging.

Additionally, it offers essential products used in the everyday operation of neonatal intensive care unit (NICU); balance assessment systems to evaluate patients with balance disorders; and NICVIEW, a live streaming video for families with babies in the NICU.

The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation for hearing and balance care professionals.

It serves university medical centers, public and private hospitals, physician offices, clinics, research laboratories, and others.

The company was formerly known as ALGOTEK Instruments, Inc. and changed its name to Natus Medical Incorporated in September 1988.

Natus Medical Incorporated was incorporated in 1987 and is headquartered in Middleton, Wisconsin.

Natus Medical
Natus Medical logo
Country United States
IPO Date Jul 20, 2001
Industry Medical - Devices
Sector Healthcare
Employees 1,400
CEO Jonathan Kennedy

Contact Details

Address:
6701 Koll Center Pkwy Ste 120
Pleasanton, California
United States
Website https://www.natus.com

Stock Details

Ticker Symbol NTUS
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000878526
CUSIP Number 639050103
ISIN Number US6390501038
Employer ID 77-0154833
SIC Code 3845

Key Executives

No executives data available.

Latest SEC Filings

Date Type Title
Aug 01, 2022 15-12G Filing
Jul 22, 2022 EFFECT Filing
Jul 22, 2022 EFFECT Filing
Jul 22, 2022 EFFECT Filing
Jul 21, 2022 4 Filing
Jul 21, 2022 4 Filing
Jul 21, 2022 4 Filing
Jul 21, 2022 4 Filing
Jul 21, 2022 4 Filing
Jul 21, 2022 4 Filing